C
Chitra Sundaram
Researcher at University of Texas MD Anderson Cancer Center
Publications - 12
Citations - 7311
Chitra Sundaram is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Curcumin. The author has an hindex of 10, co-authored 12 publications receiving 6554 citations.
Papers
More filters
Journal ArticleDOI
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
Preetha Anand,Ajaikumar B. Kunnumakara,Chitra Sundaram,Kuzhuvelil B. Harikumar,Sheeja T. Tharakan,Oiki S. Lai,Bokyung Sung,Bharat B. Aggarwal +7 more
TL;DR: Evidence that inflammation is the link between the agents/factors that cause cancer and the agents that prevent it is presented and evidence that cancer is a preventable disease that requires major lifestyle changes is provided.
Book ChapterDOI
Curcumin: The Indian solid gold
TL;DR: Curcumin has been shown to exhibit antioxidant, anti-inflammatory, antiviral, antibacterial, antifungal, and anticancer activities and thus has a potential against various malignant diseases, diabetes, allergies, arthritis, Alzheimer's disease, and other chronic illnesses.
Journal ArticleDOI
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature.
Preetha Anand,Sherin G. Thomas,Ajaikumar B. Kunnumakkara,Chitra Sundaram,Kuzhuvelil B. Harikumar,Bokyung Sung,Sheeja T. Tharakan,Krishna Misra,Indira K. Priyadarsini,Kallikat N. Rajasekharan,Bharat B. Aggarwal +10 more
TL;DR: This review focuses on the status of all these approaches in generating a "super curcumin," a homodimer of feruloylmethane containing a methoxy group and a hydroxyl group, a heptadiene with two Michael acceptors, and an alpha,beta-diketone.
Journal ArticleDOI
Curcumin and cancer: An “old-age” disease with an “age-old” solution
TL;DR: The activity of curcumin reported against leukemia and lymphoma, gastrointestinal cancers, genitourinary cancers, breast cancer, ovarian cancer, head and neck squamous cell carcinoma, lung cancer, melanoma, neurological cancers, and sarcoma reflects its ability to affect multiple targets.
Journal ArticleDOI
Inhibiting NF-κB activation by small molecules as a therapeutic strategy
TL;DR: Only small molecules that suppress NF-κB activation are described, and the mechanism by which they block this pathway is described.